-
digital.ahrq.gov/ahrq-funded-projects/rheumatology-informatics-system-effectiveness-patient-reported-outcome-rise-pro/citation/quality
January 01, 2023 - Quality improvement initiatives in rheumatology: an integrative review of the last 5 years. … Quality improvement initiatives in rheumatology: an integrative review of the last 5 years.
-
digital.ahrq.gov/ahrq-funded-projects/improving-outpatient-safety-older-adults-through-electronic-patient-portals/citation/improving
January 01, 2023 - Use of electronic health records by older adults, 85 years and older, and their caregivers. … Use of electronic health records by older adults, 85 years and older, and their caregivers.
-
digital.ahrq.gov/health-it-tools-and-resources/pediatric-resources/pediatric-rules-and-reminders/lead-high-risk-area-and-age-4-years-due
December 08, 2000 - Lead, (High risk area AND Age= 4 years), Due for Screening
Clinician Summary
American Academy … If children are exposed to lead, their BLLs tend to increase during ages 0--2 years and peak at ages … Therefore, screening is recommended at both ages 1 and 2 years to identify children who need medical … In addition, a child with a BLL <10 µg/dL at age 1 year might have an elevated level by age 2 years, … underscoring the importance of rescreening at age 2 years.
-
digital.ahrq.gov/health-it-tools-and-resources/health-it-costs-and-benefits-database/functional-gaps-attaining
What will it take to get there in five years?
Authors: Kaushal, R., Bates, D. … between the HIT functionalities specified in the model and the estimated HIT functionalities in five years … Years of study: Not specified Study Design: Predictive analysis Outcomes: Gaps in HIT functionalities … Description: Key functionality of a national health information network to be established in five years … Implementation: In five years it was projected that automated claims submission would be available in
-
digital.ahrq.gov/sites/default/files/docs/page/lead-screening-due-high-risk-age-4y.pdf
December 08, 2000 - Pediatric Rules and Reminders - Lead, (High risk area AND Age= 4 years), Due for Screening … Pediatric Rules and Reminders
Lead, (High risk area AND Age= 4 years), Due for Screening … If children are exposed to lead, their BLLs tend to increase during ages 0--2 years
and peak at ages … In addition, a child with a BLL <10 µg/dL at age 1 year might have an elevated level
by age 2 years … , underscoring the importance of rescreening at age 2 years.
-
digital.ahrq.gov/sites/default/files/docs/resource/Mostashari_List_of_Measures_TCNY_AQA_eQARR_Crosswalk_1_30_08_Mostashari.pdf
May 29, 2009 - Advising
Smokers to Quit
The percentage of
members, 18 years
and older, who are
either current … >=
35 years of age
and female
patients >=45
years of age
without IVD or
Diabetes who
have a total … who had a
mammogram in the
past two years. … past 3
years. … For Child
Health Plus, the
reporting age group
is 5 to 18 years.
-
digital.ahrq.gov/health-it-tools-and-resources/pediatric-resources/pediatric-rules-and-reminders/lead-age-2-years-due-screening
December 08, 2000 - Lead, (Age= 2 years), Due for Screening
Clinician Summary
American Academy of Pediatrics … If children are exposed to lead, their BLLs tend to increase during ages 0--2 years and peak at ages … Therefore, screening is recommended at both ages 1 and 2 years to identify children who need medical … In addition, a child with a BLL <10 µg/dL at age 1 year might have an elevated level by age 2 years, … underscoring the importance of rescreening at age 2 years.
-
digital.ahrq.gov/health-it-tools-and-resources/pediatric-resources/pediatric-rules-and-reminders/lead-age-3-years-due-screening
December 08, 2000 - Lead, (Age = 3 years), Due for Screening
Clinician Summary
American Academy of Pediatrics … If children are exposed to lead, their BLLs tend to increase during ages 0--2 years and peak at ages … Therefore, screening is recommended at both ages 1 and 2 years to identify children who need medical … In addition, a child with a BLL <10 µg/dL at age 1 year might have an elevated level by age 2 years, … underscoring the importance of rescreening at age 2 years.
-
digital.ahrq.gov/sites/default/files/docs/page/lead-screening-due-age-2y.pdf
December 08, 2000 - Pediatric Rules and Reminders - Lead, (Age= 2 years), Due for Screening
Pediatric Rules and … Reminders
Lead, (Age= 2 years), Due for Screening
Clinician Summary
American Academy of Pediatrics … If children are exposed to lead, their BLLs tend to increase during ages 0--2 years
and peak at ages … In addition, a child with a BLL <10 µg/dL at age 1 year might have an elevated level
by age 2 years … , underscoring the importance of rescreening at age 2 years.
-
digital.ahrq.gov/sites/default/files/docs/page/lead-screening-due-age-3y.pdf
December 08, 2000 - Pediatric Rules and Reminders - Lead, (Age = 3 years), Due for Screening
Pediatric Rules and … Reminders
Lead, (Age = 3 years), Due for Screening
Clinician Summary
American Academy of … If children are exposed to lead, their BLLs tend to increase during ages 0--2 years
and peak at ages … In addition, a child with a BLL <10 µg/dL at age 1 year might have an elevated level
by age 2 years … , underscoring the importance of rescreening at age 2 years.
-
digital.ahrq.gov/sites/default/files/docs/resource/Logan_ExcellenceReportExample.pdf
March 15, 2009 - age with no abnormal finding
Of these, recommended followup interval
< 10 years
= 10 years
> … 5 - 10 years
< 5 years
No surveillance interval documented
0 (0% )
0 (0% )
0 (0% )
14 (100% … )
3-10 adenomas (3 years)
> 10 adenomas (<3 years) Details
adenoma with villous features (3 years)
adenoma … )3-10 adenomas (3 years)> 10 adenomas (<3 years)adenoma with villous features (3 years)adenoma >= 1 cm … mos)hyperplastic polyp (10 years for screening, 5-10 years for suveillance)
-
digital.ahrq.gov/dhr-20
January 01, 2023 - Anniversary Blog Series Healthcare’s Next Technological Frontier: 21st Century Artificial Intelligence 20 Years … Research from AHRQ’s Digital Healthcare Research Program AHRQ’s Digital Healthcare Research Program: 20 Years … Decision Support: Building the Bridge to Evidence-based Medicine New JAMIA Article Captures DHR's 20 Years … of Advancing Innovation and Discovery AHRQ’s digital healthcare research program: 20 years of advancing
-
digital.ahrq.gov/health-it-tools-and-resources/health-it-costs-and-benefits-database/nine-years-computerized-patient
March 01, 1997 - Nine years of computerized patient records in a small family practice
Authors: Davis, W. … Journal: Fam Pract Manag Publication Date: 1997 Mar Volume: 4 Issue: 3 Pages: 69-70, 73-6 Years
-
digital.ahrq.gov/ahrq-funded-projects/assessing-impact-patient-centered-medical-home-co
January 01, 2023 - Care Coordination
Chronic Disease Management
Preventive Medicine
For more than 20 years … Because the WellMed model was implemented more than 20 years ago with a plan-do-study-act approach, it … did not show improvements, perhaps because the improvements occurred when the changes were made 10 years … time it took for WellMed to develop its model, but is likely to take much longer than the typical 2-3 years … Purchasing practices usually take 4-5 years to achieve similar outcomes once full PCMH/ACO functions
-
digital.ahrq.gov/sites/default/files/docs/implementation/Bellamy.ppt
April 01, 2005 - Time worked
--in the hospital 8.4% Less than 1 year 33.6% 1 to 5 years 24.9% 6 to 10 years
(years) … 8.7% 11 to 15 years 9.9% 16 to 20 years 14.4% 21 years or more
--in their current … to 15 years 7.2% 16 to 20 years 9.9% 21 years or more
--in their current 4.5% Less than 1 year … 24.5% 1 to 5 years 17.6% 6 to 10 years
specialty (years)
16.1% 11 to 15 years 11.3% 16 to … 20 years 26% 21 years or more
4.
-
digital.ahrq.gov/sites/default/files/docs/resource/Logan_QMforColonoscopy_Fields_v4.pdf
December 12, 2008 - Of these, number (%) with recommendation > 10 years, = 10 years, < 10 years, or no
documentation of … )
o 3-10 adenomas (3 years)
o >10 adenomas (<3 years)
o adenoma with villous features (3 years)
o … adenoma >=1 cm (3 years)
o adenoma with high grade dysplasia (3 years)
o sessile adenoma >=2 cm, … removed piecemeal (2-6 mos)
o hyperplastic polyp (10 years for screening, 5-10 years for surveillance … = 3 AND interval between 2.5 and 3.5 years) OR (type = 4 AND interval
between 4.5 and 10.5 years) OR
-
digital.ahrq.gov/health-it-tools-and-resources/health-it-costs-and-benefits-database/front-line-report-near-paperless
April 26, 2021 - Purpose of Study: assess effects on use and efficiency of continued use of an EHR Years of study: 2002 … comparison of responses to a survey done in 2002, shortly after implementation, with 2005, after about 4 years … Time needed to accrue benefit: This time period was 3+ years after initial implementation
-
digital.ahrq.gov/health-it-tools-and-resources/health-it-costs-and-benefits-database/follow-study-patients-advised
Years of study: 1983-1985 Study Design: RCT Outcomes: Impact on health care effectivness/quality Summary … Intervention: Over three years, a group with computerized reminders to use influenza prevention services … Outcome: The rate of immunizations changed from 11.1% in year one to 45.5 % in year two to 19.0% in years … three in the reminder group, and from 11.7% in year one to 16.5 % in year two to 17.7% in years three
-
digital.ahrq.gov/sites/default/files/docs/citation/r01hs023582-stockwell-final-report-2019.pdf
January 01, 2019 - for the
school-age boosters due at 4-6 years, and 13-17 years for the adolescent vaccine due at 11 … -12
years as well as the meningococcal booster due at 16 years. … 4 - 6 years 7 - 10 years 11- 12 years 13- 17 years
years
ON OFF … 2 - 3
years 4 – 6 years 7 - 10 years
11 - 12
years 13 - 17 years
p-
value
0.0001 0.0006 0.0034 … >=7 and <12 mo
>=19
and <48
mo
>=7 and
<11
years
>=13
and <16
years
>= 17 and
< 18 years
-
digital.ahrq.gov/sites/default/files/docs/resource/Logan_QMforColonoscopy_Narrative_v4.pdf
December 12, 2008 - , = 10 years, < 10 years, or no
documentation of followup. … , 5 - 10 years, > 10 years, or no
documentation of followup. … )
o 3-10 adenomas (3 years)
o >10 adenomas (<3 years)
o adenoma with villous features (3 years)
o … 3 –
10 adenomas found.
2.5 – 3.5 years (3 years) <2.5 years or >3.5 years
Adenoma (all others … years (5-10 ) <4.5 or > 10.5 years
Hyperplasia (no
adenomas) - screening
>= 9.5 years (> 10) <9.5